Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Orion Corporation Orion Pharma, FI-02200 Espoo, Finland

Femme et Homme Max 99 ans
Orion Corporation Orion Pharma, FI-02200 Espoo, Finland MAJ Il y a 4 ans

Efficacy and safety of Stalevo in subjects with early wearing-off identified using a screening tool WOQ-9; An open, non-randomised, multinational, multi-centre 6-week direct switch study in levodopa-treated Parkinson's disease patients to provide efficacy data of the direct switch from levodopa/carbidopa or levodopa/benserazide to levodopa/carbidopa/entacapone (Stalevo®) by clinical global impression of change (CGI-C) as judged by t...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations